Capture réglementaire en temps de pandémie
In the midst of the covid-19 pandemic, the Food and Drug Administration (FDA) published in March the orphan drug status granted to remdesivir, a molecule patented by Gilead as a treatment for the new coronavirus. This gave the company seven years of market exclusivity for its drug in the US market....
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Association Recherche & Régulation
2021-02-01
|
| Series: | Revue de la Régulation |
| Subjects: | |
| Online Access: | http://journals.openedition.org/regulation/17621 |